Zealand Pharma A/S
Homodetic cyclic peptides targeting alpha-4-beta-7 integrin

Last updated:

Abstract:

There is described herein antagonists of .alpha.4.beta.7 integrin, and more particularly cyclic peptide antagonists, such as compounds of formula (I).

Status:
Grant
Type:

Utility

Filling date:

10 May 2018

Issue date:

29 Mar 2022